The executive team from AstraZeneca met this week with the U.K. government to discuss the country leaving the European Union, as its CEO says there are “…

The chief of AstraZeneca, Pascal Soriot, said during the Big Pharma’s financials this morning that he wants a “science-led FDA” as President Donald Trump'…

Lobbyists and lawmakers have laid into President Donald Trump’s plan to slash the number of regulations covering drug developers.

Lawmakers have sent a letter to the White House urging Trump to come clean on what a hiring freeze means for the FDA.

Seres Therapeutics has plotted a path forward for its Clostridium difficile program after digging into the data to learn where it went wrong in phase 2.

FibroGen has posted positive phase 3 data on its AstraZeneca-partnered anemia drug.

Back in the summer, Novartis quietly announced that the FDA had rejected its application for a biosimilar version of blockbuster drug Neulasta (pegfilgrastim…

The United Kingdom government is holding a series of meetings with the CEOs of top-10 pharma companies in a bid to understand how it can attract R&D…

If reports are to be believed, the latest addition to Trump's list of possible FDA commissioners is Dr. Joseph Gulfo, an outspoken critic of the agency.

The U.K. government wants to strike a deal to boost the productivity of the life science sector.

Regulatory